Brief: China Grand Pharma And Healthcare Says Unit Entered Subscription Agreement
02/07/2021 02:58
July 2 (Reuters) - China Grand Pharmaceutical and Healthcare
Holdings Ltd 0512.HK :
* UNIT ENTERED INTO SUBSCRIPTION AGREEMENT WITH NATIXIS AND
SIRTEX
HOLDCO
* GRAND DECADE TO SUBSCRIBE FOR 84.7 MILLION SIRTEX HOLDCO
SHARES
FOR US$100 MILLION
* NATIXIS TO SUBSCRIBE FOR 4.00% OF OF SIRTEX HOLDCO FOR
US$50
MILLION
Source text for Eikon: ID:nHKS9KQqVV
Further company coverage: 0512.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement